Clinical Trials
26 trialsIntralesional HPV Vaccine for Condylomata
University of California, San Francisco
Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer
Galderma R&D
Evaluate the Effectiveness and the Safety of a Medical Device in the Treatment of Common Warts and Plantar Warts.
Swiss Footcare Laboratories - Poderm Professional
COVE-1
Verrica Pharmaceuticals Inc.
CARE-1
Verrica Pharmaceuticals Inc.
Intralesional Vitamin D Injection for Treatment of Common Warts
Mayo Clinic
Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca
Medical University of South Carolina
CellFX Comparison to Cryosurgery in Cutaneous Non-Genital Common Warts
Pulse Biosciences, Inc.
CellFX System for the Treatment of Cutaneous Non-Genital Warts
Pulse Biosciences, Inc.
Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome
National Institutes of Health Clinical Center (CC)
Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands
Cleveland Clinic Akron General
MMR
B.P. Koirala Institute of Health Sciences
Candin Safety & Efficacy Study for the Treatment of Warts
Nielsen BioSciences, Inc.
Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls?
Medstar Health Research Institute
Safety Study of A-101 Topical Solution for the Treatment of Common Warts
Aclaris Therapeutics, Inc.
A Study of A-101 Topical Solution for the Treatment of Common Warts
Aclaris Therapeutics, Inc.
Study of A-101 Topical Solution for the Treatment of Common Warts
Aclaris Therapeutics, Inc.
Nanopulse Efficacy Study for the Treatment of Common Warts
University of Southern California
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Nielsen BioSciences, Inc.
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Common Warts
ViroXis Corporation
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
Aclaris Therapeutics, Inc.
A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts
Aclaris Therapeutics, Inc.
A Study of A-101 Solution in Subjects With Common Warts.
Aclaris Therapeutics, Inc.
Investigating Veregen â„¢ 15% Ointment Treatment For Non-facial Verrucae in Pediatric Patients: A Pilot Study
University of Texas Southwestern Medical Center
Treatment of Oral Warts in HIV+ Patients
Ainos, Inc. (f/k/a Amarillo Biosciences Inc.
Study With Candida Antigen for Treatment of Warts
University of Arkansas